Header cover image

Mexican (IPC) Pharma Industry Analysis

UpdatedApr 28, 2024
DataAggregated Company Financials
Companies1
  • 7D8.2%
  • 3M15.2%
  • 1Y9.1%
  • YTDn/a

All of the companies in the Pharma industry have been up over the last week, with the industry up 7.1%. Despite this gain, the industry's performance has been flat over the past year. Earnings are forecast to grow by 27% annually.

Industry Valuation and Performance

Has the Mexican Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 28 Apr 2024Mex$15.2bMex$16.5bMex$1.0b14.5x14.5x0.9x
Tue, 26 Mar 2024Mex$14.0bMex$16.5bMex$1.0b13.6x13.6x0.9x
Thu, 22 Feb 2024Mex$11.7bMex$17.1bMex$1.4b8.3x8.4x0.7x
Sat, 20 Jan 2024Mex$12.6bMex$17.1bMex$1.4b9.1x9.1x0.7x
Mon, 18 Dec 2023Mex$12.6bMex$17.1bMex$1.4b9x9x0.7x
Wed, 15 Nov 2023Mex$12.9bMex$17.1bMex$1.4b9.3x9.3x0.8x
Fri, 13 Oct 2023Mex$12.8bMex$17.0bMex$1.4b9x9x0.7x
Sun, 10 Sep 2023Mex$13.7bMex$17.0bMex$1.4b9.6x9.6x0.8x
Tue, 08 Aug 2023Mex$13.9bMex$17.0bMex$1.4b9.8x9.8x0.8x
Thu, 06 Jul 2023Mex$13.3bMex$17.0bMex$1.4b9.4x9.4x0.8x
Sat, 03 Jun 2023Mex$15.0bMex$17.0bMex$1.4b10.6x10.6x0.9x
Mon, 01 May 2023Mex$14.9bMex$17.0bMex$1.4b10.5x10.5x0.9x
Wed, 29 Mar 2023Mex$13.9bMex$16.9bMex$1.4b9.9x9.9x0.8x
Fri, 24 Feb 2023Mex$17.2bMex$16.8bMex$1.4b11.4x12.7x1x
Sun, 22 Jan 2023Mex$17.4bMex$16.8bMex$1.4b12.8x12.8x1x
Tue, 20 Dec 2022Mex$17.4bMex$16.8bMex$1.4b12.8x12.8x1x
Thu, 17 Nov 2022Mex$15.7bMex$16.8bMex$1.4b11.6x11.6x0.9x
Sat, 15 Oct 2022Mex$13.1bMex$16.4bMex$1.4b9.7x9.7x0.8x
Mon, 12 Sep 2022Mex$15.6bMex$16.4bMex$1.4b11.6x11.6x1x
Wed, 10 Aug 2022Mex$16.9bMex$16.4bMex$1.4b12.5x12.5x1x
Fri, 08 Jul 2022Mex$20.6bMex$15.9bMex$1.5b14x14x1.3x
Sun, 05 Jun 2022Mex$19.7bMex$15.9bMex$1.5b13.4x13.4x1.2x
Tue, 03 May 2022Mex$21.3bMex$15.9bMex$1.5b14.5x14.5x1.3x
Thu, 31 Mar 2022Mex$22.0bMex$15.5bMex$1.5b15.2x15.2x1.4x
Sat, 26 Feb 2022Mex$18.8bMex$15.5bMex$1.5b12.9x12.9x1.2x
Mon, 24 Jan 2022Mex$19.6bMex$14.9bMex$1.4b13.8x13.8x1.3x
Wed, 22 Dec 2021Mex$21.2bMex$14.9bMex$1.4b15x15x1.4x
Fri, 19 Nov 2021Mex$18.8bMex$14.9bMex$1.4b13.2x13.2x1.3x
Sun, 17 Oct 2021Mex$19.6bMex$14.3bMex$1.4b13.7x13.7x1.4x
Tue, 14 Sep 2021Mex$21.1bMex$14.3bMex$1.4b14.7x14.7x1.5x
Thu, 12 Aug 2021Mex$18.9bMex$14.3bMex$1.4b13.2x13.2x1.3x
Mon, 07 Jun 2021Mex$21.1bMex$14.1bMex$1.4b14.9x14.9x1.5x
Price to Earnings Ratio

14.4x


Total Market Cap: Mex$20.4bTotal Earnings: Mex$1.4bTotal Revenue: Mex$14.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Mexican Pharma Industry Price to Earnings3Y Average 12.2x202220232024
Current Industry PE
    There is only one company in the Mexican Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 10% per year over the last three years.
  • Meanwhile revenues for these companies have grown 5.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Mexican Pharma compare with similar industries?

MX Market2.44%
Healthcare6.40%
Pharma8.23%
Pharma8.23%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LAB B Genomma Lab Internacional. deMex$16.308.2%
+Mex$1.2b		9.1%PE14.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

LAB B

Mex$16.30

Genomma Lab Internacional. de

7D

8.2%

1Y

9.1%